Hepatoma Research
All Journals
Search Log In
Home Articles Special Issues Volumes Webinars Videos
Hepatoma Research
Search Submit
Home Articles Special Issues Volumes Webinars Videos

fig2

From:  The role of immune checkpoint inhibitors and/or Yttrium-90 radioembolization in the management of hepatocellular carcinoma: challenges of treatment sequence
The role of immune checkpoint inhibitors and/or Yttrium-90 radioembolization in the management of hepatocellular carcinoma: challenges of treatment sequence

Figure 2. Image of Y90 RE procedure. This figure was re-printed with copyright permission from ref.[42]. Y90: Yttrium-90; RE: radioembolization.

Hepatoma Research
ISSN 2454-2520 (Online) 2394-5079 (Print)
Navigation
Follow Us
Navigation

Portico

All published articles are preserved here permanently:

https://www.portico.org/publishers/oae/

Portico

All published articles are preserved here permanently:

https://www.portico.org/publishers/oae/
Discover Content
Follow OAE
Twitter
Facebook
LinkedIn
YouTube
BiLiBiLi
WeChat
© 2016-2024 OAE Publishing Inc., except certain content provided by third parties